Literature DB >> 22798545

The management of febrile neutropenia in the posaconazole era: a new challenge?

Livio Pagano, Morena Caira, Manuel Cuenca-Estrella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22798545      PMCID： PMC3396663          DOI： 10.3324/haematol.2012.062166

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  33 in total

1.  Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.

Authors:  P Campoli; Q Al Abdallah; R Robitaille; N V Solis; J A Fielhaber; A S Kristof; M Laverdiere; S G Filler; D C Sheppard
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 2.  Detection and investigation of invasive mould disease.

Authors:  Manuel Cuenca-Estrella; Matteo Bassetti; Cornelia Lass-Flörl; Zdenek Rácil; Malcolm Richardson; Thomas R Rogers
Journal:  J Antimicrob Chemother       Date:  2011-01       Impact factor: 5.790

3.  The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.

Authors:  Livio Pagano; Morena Caira; Annamaria Nosari; Chiara Cattaneo; Rosa Fanci; Alessandro Bonini; Nicola Vianelli; Maria Grazia Garzia; Mario Mancinelli; Maria Elena Tosti; Mario Tumbarello; Pierluigi Viale; Franco Aversa; Giuseppe Rossi
Journal:  Haematologica       Date:  2011-05-12       Impact factor: 9.941

4.  Posaconazole: clinical pharmacokinetics and drug interactions.

Authors:  Hans-Peter Lipp
Journal:  Mycoses       Date:  2011-01       Impact factor: 4.377

5.  Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.

Authors:  Elaine McCulloch; Gordon Ramage; Ranjith Rajendran; David F Lappin; Brian Jones; Peter Warn; Raghdaa Shrief; William R Kirkpatrick; Thomas F Patterson; Craig Williams
Journal:  J Clin Pathol       Date:  2011-11-02       Impact factor: 3.411

6.  Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole.

Authors:  Mauricette Michallet; Mohamad Sobh; Stéphane Morisset; Samira Kraghel; Franck-Emmanuel Nicolini; Xavier Thomas; Anne-Lise Bienvenu; Stéphane Picot; Marie-Christine Nicolle; Philippe Vanhems
Journal:  Med Mycol       Date:  2011-02-11       Impact factor: 4.076

7.  Early implementation of antifungal therapy in the management of febrile neutropenia is associated with favourable outcome during induction chemotherapy for acute leukaemias.

Authors:  A Khalafallah; M Maiwald; T Hannan; S Abell; J Staker; A Supperamohan
Journal:  Intern Med J       Date:  2012-02       Impact factor: 2.048

8.  Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends.

Authors:  Morena Caira; Mario Mancinelli; Giuseppe Leone; Livio Pagano
Journal:  Med Mycol       Date:  2010-08-26       Impact factor: 4.076

9.  Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.

Authors:  Ban Hock Tan; Jenny Guek Hong Low; Nidhi L Chlebicka; Asok Kurup; Foong Koon Cheah; Raymond Tzer Pin Lin; Yeow Tee Goh; Gee Chuan Wong
Journal:  Int J Infect Dis       Date:  2011-03-11       Impact factor: 3.623

10.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Authors:  J Maertens; O Marchetti; R Herbrecht; O A Cornely; U Flückiger; P Frêre; B Gachot; W J Heinz; C Lass-Flörl; P Ribaud; A Thiebaut; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2010-07-26       Impact factor: 5.483
View more
  3 in total

1.  Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).

Authors:  Morena Caira; Anna Candoni; Luisa Verga; Alessandro Busca; Mario Delia; Annamaria Nosari; Cecilia Caramatti; Carlo Castagnola; Chiara Cattaneo; Rosa Fanci; Anna Chierichini; Lorella Melillo; Maria Enza Mitra; Marco Picardi; Leonardo Potenza; Prassede Salutari; Nicola Vianelli; Luca Facchini; Monica Cesarini; Maria Rosaria De Paolis; Roberta Di Blasi; Francesca Farina; Adriano Venditti; Antonella Ferrari; Mariagrazia Garzia; Cristina Gasbarrino; Rosangela Invernizzi; Federica Lessi; Annunziata Manna; Bruno Martino; Gianpaolo Nadali; Massimo Offidani; Laura Paris; Vincenzo Pavone; Giuseppe Rossi; Antonio Spadea; Giorgina Specchia; Enrico Maria Trecarichi; Adriana Vacca; Simone Cesaro; Vincenzo Perriello; Franco Aversa; Mario Tumbarello; Livio Pagano
Journal:  Haematologica       Date:  2015-02       Impact factor: 9.941

Review 2.  Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).

Authors:  Can Boğa; Zahit Bolaman; Seçkin Çağırgan; İhsan Karadoğan; Mehmet Ali Özcan; Fahir Özkalemkaş; Rabin Saba; Mehmet Sönmez; Esin Şenol; Hamdi Akan; Murat Akova
Journal:  Turk J Haematol       Date:  2015-06       Impact factor: 1.831

3.  The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study

Authors:  Vildan Özkocaman; Fahir Özkalemkaş; Serdar Seyhan; Beyza Ener; Ahmet Ursavaş; Tuba Ersal; Esra Kazak; Ezgi Demirdöğen; Reşit Mıstık; Halis Akalın
Journal:  Turk J Haematol       Date:  2018-07-26       Impact factor: 1.831
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.